Drug class
Carbonic Anhydrase Inhibitors
Carbonic anhydrase inhibitors are a distinct pharmacologic class of medications that reversibly inhibit the zinc metalloenzyme carbonic anhydrase across multiple tissues. Read more about Carbonic Anhydrase Inhibitors
54 drugs in this class 44 manufacturers
Drugs in Carbonic Anhydrase Inhibitors
ACETAZOLAMIDE
ACETAZOLAMIDE
ACETAZOLAMIDE
METHAZOLAMIDE
ACETAZOLAMIDE
ACETAZOLAMIDE
ACETAZOLAMIDE
ACETAZOLAMIDE ER (acetazolamide)
Carbonic anhydrase inhibitors are a distinct pharmacologic class of medications that reversibly inhibit the zinc metalloenzyme carbonic anhydrase across multiple tissues.
By blocking the interconversion of carbon dioxide and bicarbonate, these agents suppress bicarbonate reabsorption in the renal proximal tubules, reduce aqueous humor production in the ciliary body, and diminish cerebrospinal fluid secretion.
Clinically, they are primary therapies for lowering intraocular pressure in glaucoma and ocular hypertension, managing idiopathic intracranial hypertension, and preventing or treating acute altitude sickness.
They also serve as adjunctive therapies for selected seizure disorders and metabolic alkalosis, as well as mild diuretics in edematous states.
-
fda.gov
Carbonic anhydrase inhibitors are a distinct pharmacologic class of medications that reversibly inhibit the zinc metalloenzyme carbonic anhydrase across multiple tissues By blocking the interconversion of carbon dioxide and bicarbonate, these agents suppress bicarbonate reabsorption in the renal proximal tubules, reduce aqueous humor production in the ciliary body, and diminish cerebrospinal fluid secretion
-
nih.gov
Carbonic anhydrase inhibitors are a distinct pharmacologic class of medications that reversibly inhibit the zinc metalloenzyme carbonic anhydrase across multiple tissues By blocking the interconversion of carbon dioxide and bicarbonate, these agents suppress bicarbonate reabsorption in the renal proximal tubules, reduce aqueous humor production in the ciliary body, and diminish cerebrospinal fluid secretion Clinically, they are primary therapies for lowering intraocular pressure in glaucoma and ...
-
fda.gov
By blocking the interconversion of carbon dioxide and bicarbonate, these agents suppress bicarbonate reabsorption in the renal proximal tubules, reduce aqueous humor production in the ciliary body, and diminish cerebrospinal fluid secretion Clinically, they are primary therapies for lowering intraocular pressure in glaucoma and ocular hypertension, managing idiopathic intracranial hypertension, and preventing or treating acute altitude sickness
-
nih.gov
By blocking the interconversion of carbon dioxide and bicarbonate, these agents suppress bicarbonate reabsorption in the renal proximal tubules, reduce aqueous humor production in the ciliary body, and diminish cerebrospinal fluid secretion
-
nih.gov
Clinically, they are primary therapies for lowering intraocular pressure in glaucoma and ocular hypertension, managing idiopathic intracranial hypertension, and preventing or treating acute altitude sickness
Sign in to follow this class
Following a drug class requires a free Physicians Office Resource account.